| [1] |
WU Hui-qian, NI Heng-li, ZHOU Ai-jun, YUAN Hang, LI Jian-ming.
Tumor infiltrating lymphocytes predict the efficacy of neoadjuvant chemotherapy for breast cancer
[J]. Lingnan Modern Clinics In Surgery, 2024, 24(02): 100-105.
|
| [2] |
PENG Lin-hui, CHEN Tao, XU Yun-xiu-xiu, WANG Jie, CHEN Jie, LI Yong, HUANG Pin-bo, ZHONG Guo-ping, CHEN Qian, YE Cong-ting, CHEN Ya-jin.
mFOLFOX7 venous chemotherapy plus camrelizumab and apatinib for hepatocellular carcinoma in CNLC stage Ⅲ （VIC-TRIPLET）： a prospective study
[J]. Lingnan Modern Clinics In Surgery, 2024, 24(01): 1-6.
|
| [3] |
WAN Jian, LIU Meng-yao, LI Shuai-jie, LIU Yi-ting, LAO Xiao-xia, CHEN Yong.
Observation of bone marrow suppression and adverse reactions after chemotherapy after breast cancer surgery
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(06): 473-479.
|
| [4] |
LIN Rui, LI Guo-sheng, DANG Yi-wu, YANG Da-ping, ZENG Neng-yong, KONG Jin-liang, CHEN Gang.
Clinicopathological significance of BIRC5 mRNA and protein expression in lung adenocarcinoma
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(06): 490-497.
|
| [5] |
LIU Zi-fei, HUANG Peng-han, JIANG Yong-xue, ZENG Wen-feng.
Single-cell profiling reveals that chemotherapy potentiates antitumor immunity in breast cancer through spermidine metabolism modulation
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(05): 379-386.
|
| [6] |
LUO Xuan, LONG Yin, HUANG Zi-qi, HE Xiao-dong, HUANG Jue, LIAO Jian-guo, ZHANG Lei.
Real-world analysis of mFOLFOX systemic chemotherapy combined with immunotherapy and targeted therapy for unresectable hepatocellular carcinoma
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(04): 294-301.
|
| [7] |
LIU Cong-yong, ZHANG Lu, JIANG Hui-qi, GAO Min-nan, LI Jing-wen, SHI Zhan-yue, YANG Yan-qi, ZHENG Jun-meng.
Recurrent pericardial effusion from primary cardiac angiosarcoma leading to delayed diagnosis： a case report and literature review
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(04): 337-342.
|
| [8] |
QIAN Jun-lin, TANG Hong-tao, LIN Wei, HU Ze-min.
Research progress of hepatic arterial infusion chemotherapy with FOLFOX regimen
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(04): 347-352.
|
| [9] |
ZHOU Hua-bin, LIU Yu-lan, WANG Zhong-chang, LI Min, ZHENG Chao.
Prognostic impact of primary tumor resection combined with chemotherapy on stage Ⅳ colorectal cancer
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(03): 220-229.
|
| [10] |
ZHU Xiang-ping, GAO Zeng-hong, MA Ruo-wu, WANG Jin, LIU Ying, GUO Ya-bin.
Application of Sleeping Beauty transposon in screening lung cancer-related genes
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(02): 118-126.
|
| [11] |
GUAN Yu-ting, ZENG Guo-bin, CHEN Jian-ping, WU Xiong-jian.
Advance of adjuvant therapy after curative resection for hepatocellular carcinoma
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(02): 193-199.
|
| [12] |
HAN Le-yang, ZENG Chao, ZHAO Long.
Analysis of the effects of different sites and surgical approaches on thoracoscopic radical lung cancer surgery complicated by celiac disease
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(01): 26-30.
|
| [13] |
LI Jing-xiao, LI Guo-sheng, XU Yang, HE Rong-quan, ZHOU Hua-fu, KONG Jin-liang, CHEN Gang.
The expression of miR-130b-3p in the blood of patients with non-small cell lung cancer and its potential significance
[J]. Lingnan Modern Clinics In Surgery, 2022, 22(06): 547-554.
|
| [14] |
CHEN Wan-na, LIANG Xiao-li, ZHANG Zhan-qiang, XU He-yang, LIN Bo, ZHANG Zhao-xi, YU Ju, ZHENG Liang, HUANG Jin-yao, ZHANG Jing, LU Yi-lin, HUANG Jia-yong, LI Rui-xia, LI Jie, LV Wei-ming.
Cost-effectiveness and Qol of PEGrhGCSF prophylaxis for breast cancer patients receiving adjuvant chemotherapy
[J]. Lingnan Modern Clinics In Surgery, 2022, 22(05): 451-457.
|
| [15] |
XU Sheng-shan, WANG Zhi-gang, LU Zhu-ming.
The role of protein glycosylation in the development of lung cancer
[J]. Lingnan Modern Clinics In Surgery, 2022, 22(04): 428-432.
|
